Skip to main content
Clinical Trials/PACTR202201552774601
PACTR202201552774601
Not yet recruiting
Phase 3

Micronutrient interventions to improve infant neurocognitive development and growth in early infancy

Kings College London0 sites1,200 target enrollmentOctober 26, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Kings College London
Enrollment
1200
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kings College London

Eligibility Criteria

Inclusion Criteria

  • Pregnancy \< 20 weeks at initial pregnancy confirmation
  • Singleton pregnancy
  • Healthy, with no evidence of current severe anaemia
  • Willingness to take a daily trial product (capsule) daily from 20 weeks of pregnancy until six\-months post\-partum and for their infant to receive a daily trial product (syrup drops) from Day 8 until 6 months of age
  • Intention to remain resident in West or Central Kiang until the infant is 12 months of age

Exclusion Criteria

  • Pregnancy phase:
  • Multiple pregnancy
  • Pregnancy \=20 weeks gestation
  • Severe anaemia (\<7g/dL)
  • Any known history or evidence of chronic disease (including HIV, TB, non\-pregnancy\-induced\-hypertension or diabetes). Women will be offered HIV Voluntary Counselling and Testing (as part of routine antenatal care) and, where positive, excluded from the trial
  • Unwilling to avoid the ingestion of other micronutrient supplements during the study period
  • If the primary language of the mother is not Mandinka or Fula
  • Post\-partum / Infancy phase:
  • Very or extremely preterm infants (\< 32 weeks gestation at delivery)
  • Very low birth weight infants (\<1\.5kg at delivery)

Outcomes

Primary Outcomes

Not specified

Similar Trials